Non-invasive blood flow boost for heart attack patients
Part of Heart & circulation, Skin clinical trials.
This trial tests a non-invasive method to improve blood flow in the arm during a heart attack. It may help reduce heart muscle damage before the standard artery-opening procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a heart attack (STEMI) and arrived at the hospital within 12 hours of symptoms starting.
- You are stable enough for a procedure to open the blocked artery (primary PCI).
- You do not have an injury or problem in your arm that would prevent a blood pressure cuff from being placed.
- You are not in cardiogenic shock, have not had a cardiac arrest, and have no history of bypass surgery, cancer, or certain other medical conditions.
- You are not pregnant or within the first 6 months after giving birth.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a clot-busting medication before transferring you to advanced heart attack treatment (PCI—a procedure that opens blocked arteries) is better than waiting. It's for patients having a specific type of heart attack (STEMI) when the advanced treatment center is far away.
This trial tests a new imaging technique called μFR to help doctors decide which blockages in your heart arteries need treatment after you've had a heart attack. It may help identify which blockages are most dangerous and need fixing soon versus those that can wait.
This trial tests treatments for small blood vessel damage after a major heart attack (STEMI). If you have had a heart attack and are receiving a stent, this study may help improve recovery by targeting microvascular injury.
This trial studies whether adding a special heart “reset” step (ischemic postconditioning) and using an imaging guide during the emergency procedure can improve outcomes for people having a STEMI heart attack. It’s meant to optimize treatment when a blocked heart artery is being opened.
This trial tests a heart medication (a cardio-selective beta-blocker) given during a heart attack to see if it reduces damage to the heart muscle. It might help people having their first heart attack who are treated quickly with angioplasty (a procedure to open blocked arteries).
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
Hear when a new STEMI - ST Elevation Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.